Related Experiment Video
Updated: Apr 6, 2026
Seven Steps to Stellate Cells
Published on: May 10, 2011
Inhibitory effects of dimethyl α-ketoglutarate in hepatic stellate cell activation
Jianjian Zhao1, Lei Peng2, Zheng Luo2
1Department of Geriatric Gastroenterology, Qilu Hospital of Shandong University Jinan, Shandong, China ; Key Laboratory of Cardiovascular Remodeling, Qilu Hospital of Shandong University Jinan, Shandong, China.
Aim:
The activation of Hepatic stellate cell (HSC) is a pivotal event in the initiation and progression of hepatic fibrosis and a major source of collagen deposition. A recent study found that autophagy fuels the HSC activation. α-ketoglutarate (AKG), an intermediate in the Kerbs CYCLE, has been shown to regulate the level of autophagy. In this study, we aim to investigate the potential effect of dimethyl α-ketoglutarate (DMKG), a membrane-permeable esters of AKG, on the activation of HSC.
Methods:
HSC and hepatocyte cell lines were treated with DMKG at gradient concentrations, MTT assay was used to assess the cell viability. Concentrations of DMKG that did not affect the cell survival were added to the culture media of HSC cells. Real-time PCR and western blot analysis was carried out to evaluate the expression of fibrogenic genes in HSC after culture for 24 hours.
Results:
Low dose of DMKG had little cytotoxicity to both HSCs and hepatocytes, while HSCs were more vulnerable to high dose of DMKG than hepatocytes. More importantly, DMKG inhibited the expression of α-SMA and collagen I significantly in HSCs detected by real-time PCR and western blot analysis at the concentrations that didn't decrease cell viability.
Conclusions:
DMKG has a significant role of inhibiting the activation of HSC and may attenuate hepatic fibrosis safely.
